Magnitude Biosciences Ltd Alternatives & Competitors
12 companies similar to Magnitude Biosciences Ltd — Accelerating R&D with In Vivo C. elegans Data & WormGazer® Technology, De-Riskin...
Panome Bio
Better -Omics for Bigger Impact.
Saint Louis, United State...
HOLTRA
Holographic particle tracking - the future of particle characterization.
Gothenburg, Sweden
Totient - Part of Absci
Artificial Intelligence for Drug Discovery
Cambridge, United States
ProFound Therapeutics
Pioneering the expanded human proteome to reveal a universe of new medicines.
Track all Magnitude Biosciences Ltd competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Vala Sciences
Vala enables precision drug discovery with fully automated analysis of hiPSC single-cell k...
San Diego, United States
Anthrogen
Molecular machines for human and planetary health.
San Francisco, United Sta...
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innova...
Cambridge, United Kingdom
Cellcolabs
Cellcolabs mission is to prevent and cure diseases by making high quality stem cells avail...
Solna, Sweden
Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...
Boston, United States
Atrandi Biosciences
Semi-Permeable Capsules (SPCs) for single-cell analysis and multiomics at scale
Vilnius, Lithuania
Promatix Biosciences Ltd
Using multi-omics to develop the next generation of cancer therapeutics
London, United Kingdom
SeNostic GmbH
Medical Innovations For Neurodegenrations
Hannover, Germany
About Magnitude Biosciences Ltd
Accelerating R&D with In Vivo C. elegans Data & WormGazer® Technology, De-Risking Clinical Trials and Cutting Costs
Whole-organism high-throughput screening, Customized C. elegans studies, Contract research services, Disease modeling, Data analysis and reporting
Pharmaceutical companies, Biotechnology firms, Nutraceuticals and ingredients developers, Cosmeceutical companies, Academic institutions
C. Elegans, R&D Acceleration, In Vivo Assays, Drug Discovery, Biotech Innovation, Ageing Research, Clinical Trial De-risking, Health Outcome Measurement, Non-invasive Assays, Compound Screening, Mutant Testing, Automation Technology, Biopharmaceuticals, Signalling Pathway Analysis, Standardised Assays
B2B, B2D, SaaS
Service Fee, Usage Based, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Magnitude Biosciences Ltd and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Magnitude Biosciences Ltd on 11 Mar 2026. The 12 companies listed here were last checked between 13 Nov 2025 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
